Lausanne, Switzerland

Jacques Lemaître

This inventor holds 1 USPTO granted patent. Top assignees: Boehringer Ingelheim Pharma Gmbh & Co Kg, Ecole Polytechnique Federale De Lausanne, Ingelheim Am Rhein. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Lemaître. Retrieved from https://idiyas.com/inventor/jacques-lemaître

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacques Lemaître: Innovator in Inhalable Medicaments

Introduction

Jacques Lemaître is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of inhalable medicaments, particularly through his innovative patent.

Latest Patents

Lemaître holds a patent for a "Process for the manufacture of powders of inhalable medicaments." This invention relates to an improved process for the production of powders by crystallization from a supersaturated fluid containing the medicament. The method involves passing the fluid along a tubular reactor, enhancing the efficiency and effectiveness of inhalable medications.

Career Highlights

Throughout his career, Jacques Lemaître has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim Pharma GmbH & Co. KG and Ingelheim am Rhein. His work in these organizations has contributed to advancements in the production of inhalable medicaments.

Collaborations

Lemaître has collaborated with several professionals in his field, including Nathalie Jongen and Paul Bowen. These collaborations have further enriched his work and innovations in inhalable medicaments.

Conclusion

Jacques Lemaître's contributions to the field of inhalable medicaments through his innovative patent and career in the pharmaceutical industry highlight his role as a significant inventor. His work continues to impact the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…